Cosmetics Provisions Unlikely To Catch Ride On FDA User-Fee Bill

With the release of an atypically lean, clean FDA user-fee reauthorization draft bill, it’s doubtful that cosmetics regulatory reform language will get tacked onto the must-pass legislation. Stakeholders likely will refocus their efforts on standalone cosmetics legislation to modernize FDA’s oversight of the industry.

Young caucasian tourist hitchhiking along a road in sunset

Standalone cosmetics legislation may now be the best bet for regulatory reform following the release of draft user-fee reauthorization legislation largely free of the add-ins and tag-alongs that have made previous iterations mini FDA-reform bills.

And that means that advocates for an update to the cosmetics regulatory framework may be in for a wait or at least face an uphill struggle, as such reform is not expected to be

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legislation

More from Policy & Regulation